Close

Moderna (MRNA) submitted a request for EUA for Omicron-targeting bivalent COVID19 vaccine

September 23, 2022 12:16 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Moderna (NASDAQ: MRNA) submitted a request for EUA for Omicron-targeting bivalent COVID19 vaccine



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News, FDA

Related Entities

FDA